This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
I am going to start with the answer to the question of whether statins cause dementia and then provide the details backing up my answer. Statins do not cause dementia. But if you are someone who thinks that statins do cause dementia and you need to see the evidence to refute that claim, then read on. The answer is: No.
Being a carrier of the APOE4 gene variant is associated with higher rates of the most common type of dementia, late-onset dementia. Of those with late-onset dementia, up to 65% are carriers of the APOE4 gene variant 1. A subsequent article will focus on the risk of late-onset dementia for those carriers of APOE4.
Type 2 Diabetes When it comes to the increasing the risk of major chronic diseases such as cardiovasculardisease, many cancers and dementia, type 2 diabetes plays a huge role. For example, people with type 2 diabetes are 10 times more likely to develop cardiovasculardisease than those who do not have diabetes 10.
BACKGROUND:Many studies have explored whether individual plasma protein biomarkers improve cardiovasculardisease risk prediction. We sought to investigate the use of a plasma proteomics-based approach in predicting different cardiovascular outcomes.METHODS:Among 51 859 UK Biobank participants (mean age, 56.7
There has been considerable progress in the prevention and treatment of cardiovasculardisease, reducing the population burden of cardiovascular morbidity and mortality. Here, we review these obstacles, motivated by SPRINT and the context of selecting an appropriate cognitive end point for future preventive randomized trials.
Insulin resistance is a major risk factor for the leading causes of death, the leading one being cardiovasculardisease. Understanding where you sit on this continuum is a key part of defining your future risk of heart disease but also dementia, and many cancers. The higher the score, the higher the risk. Circulation.
The hypothesis that a raised cholesterol level causes heart disease [atherosclerotic cardiovasculardisease (ASCVD)] is possibly the single most powerful idea in medicine. Which remains the single most influential study on cardiovasculardisease, ever. At least some of it. It was simply a matter of time.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content